JDBIO Co., Ltd.
Richesse Eyes
Brand
JDBIO Co., Ltd.
Category
Skin Booster
Origin
Korea
Interested in ordering Richesse Eyes? Send an enquiry and our team will follow up with availability and pricing.
Overview
Richesse Eyes is a polynucleotide (PN) skinbooster from Korean manufacturer JDBIO, designed for needle mesotherapy of the eye area and tear trough. Salmon-derived DNA fragments are micro-injected to regenerate and strengthen thin periorbital skin and improve elasticity and radiance, with a light filling effect rather than true volumisation. It targets under-eye skin quality and resilience.
How it works
Polynucleotide / sodium DNA from salmon induces tissue regeneration and enhances the self-healing capacity of damaged skin cells from the epidermis through the deep dermis. This strengthens the skin barrier and supports collagen and elastin, improving firmness, elasticity and a natural healthy glow around the eyes.
Indications
- Dark circles and tired under-eyes
- Fine lines and crepey periorbital skin
- Loss of elasticity and firmness
- Weak or compromised skin barrier
- Dull eye contour needing radiance
Key features
- Salmon-derived PN (sodium DNA) for the eye area
- Formulated for tear-trough mesotherapy
- Light filling effect without structural volumising
- 1.1 mL pre-filled syringe format
- From Korean manufacturer JDBIO
Benefits
- Dedicated eye-area PN option for the menu
- Barrier-strengthening, regeneration-focused positioning
- Suits skin-quality-led under-eye protocols
- Course-based use supports repeat appointments
- Complements facial PDRN/PN boosters
Composition
Polynucleotide (sodium DNA) approximately 2 mg/mL (0.2%), derived from salmon; supplied in a 1.1 mL syringe.
Usage & handling
Professional use only. Delivered by fine-needle mesotherapy to the eye area and tear trough. Supplied as a 1.1 mL pre-filled syringe. Store protected from light per manufacturer guidance; do not freeze.
For medical professionals. Product information is for reference and does not replace the manufacturer's instructions for use. Availability and regulatory status vary by region.